|
Diabetes Care, Vol 20, Issue 1 32-35, Copyright © 1997 by American Diabetes Association
Cognitive function in younger type II diabetes
J Dey, A Misra, NG Desai, AK Mahapatra and MV Padma
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
OBJECTIVE: To examine central nervous system involvement as a possible
complication of diabetes by performing a comprehensive neuropsychological
evaluation of relatively young (age < 55 years) NIDDM patients and a
group of control subjects. RESEARCH DESIGN AND METHODS: A cross-sectional
comparative study of 28 patients, with duration of diabetes 5-18 years
(mean +/- SD +/- 3.2 years), screened for acceptable glycemic control and
absence of hypoglycemia on the day of examination, compared with 28
demographically similar, nondiabetic control subjects. Neuropsychometric
tests performed were Mini-Mental Status Examination (MMSE), Neurobehavioral
Cognitive Status Examination (NCSE), and P300 latencies (endogenous evoked
potentials). RESULTS: Seven (25.0%) patients reported history suggestive of
cognitive impairment during day-to-day activities, and 17 (60.7%) had
distal symmetrical polyneuropathy. Average P300 latencies were
significantly delayed among the diabetic patients compared with the control
subjects (349.5 +/- 28.2 vs. 312.9 +/- 19.3 ms; t = 5.68, P < 0.001).
Although there was no significant difference in MMSE scores, compared with
control subjects significantly more patients had impairment in NCSE tests
of attention (chi 2 = 7.38, P < 0.01), repetition (chi 2 = 4.073, P <
0.05), and memory (chi 2 = 5.83, P < 0.05), while there was no
significant difference in tests of comprehension, naming, construction, and
calculation. Duration of diabetes, HbA1c levels, and the presence of distal
symmetrical polyneuropathy among patients each did not correlate with any
of the parameters of cognitive function evaluated. Higher blood glucose
levels during the electrophysiological testing were associated with less
delay in P300 latencies among the patients. CONCLUSIONS: Central nervous
system impairment, manifesting as mild impairments in certain cognitive
skills, should be recognized as a possible complication of long-standing
NIDDM, even in relatively younger individuals.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. L. Xiong, B. L. Plassman, M. J. Helms, and D. C. Steffens
Vascular risk factors and cognitive decline among elderly male twins.
Neurology,
November 14, 2006;
67(9):
1586 - 1591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Suh, Y. Fan, S. M. Hong, Z. Liu, Y. Matsumori, P. R. Weinstein, R. A. Swanson, and J. Liu
Hypoglycemia Induces Transient Neurogenesis and Subsequent Progenitor Cell Loss in the Rat Hippocampus
Diabetes,
February 1, 2005;
54(2):
500 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tabbarah, E. M. Crimmins, and T. E. Seeman
The Relationship Between Cognitive and Physical Performance: MacArthur Studies of Successful Aging
J. Gerontol. A Biol. Sci. Med. Sci.,
April 1, 2002;
57(4):
M228 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Asimakopoulou and S. E. Hampson
Cognitive Functioning and Self-Management in Older People With Diabetes
Diabetes Spectr,
April 1, 2002;
15(2):
116 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Lindeman, L. J. Romero, A. LaRue, C. L. Yau, D. S. Schade, K. M. Koehler, R. N. Baumgartner, and P. J. Garry
A Biethnic Community Survey of Cognition in Participants With Type 2 Diabetes, Impaired Glucose Tolerance, and Normal Glucose Tolerance: The New Mexico Elder Health Survey
Diabetes Care,
September 1, 2001;
24(9):
1567 - 1572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kumari, E. Brunner, and R. Fuhrer
Minireview: Mechanisms by Which the Metabolic Syndrome and Diabetes Impair Memory
J. Gerontol. A Biol. Sci. Med. Sci.,
May 1, 2000;
55(5):
228B - 232.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. N. Haan, L. Shemanski, W. J. Jagust, T. A. Manolio, and L. Kuller
The Role of APOE{epsilon}4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons
JAMA,
July 7, 1999;
282(1):
40 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|